Skip to main content

Table 1 miR-675-5p expression and clinicopathological features in non-small cell lung cancer(NSCLC) patients

From: Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer

Variable miR-675-5p expression
Cases Low High P-value a
Age(years)b     
<57 58 43 (74%) 15 (26%) 0.8998
≥57 22 16 (73%) 6 (27%)  
Gender     
Male 33 24 (73%) 9 (27%) 0.8750
Female 47 35 (74%) 12 (26%)  
Smoking history (years)b     
<10 36 24 (67%) 12 (33%) 0.2094
≥10 44 35 (80%) 9 (20%)  
Pathological type     
adenocarcinoma 38 30 (79%) 8 (21%) 0.3391
squamous carcinoma 42 29 (69%) 13 (71%)  
Tumor differentiation     
I + II 46 37 (80%) 9 (20%) 0.0787
III + IV 34 22 (65%) 12 (35%)  
TNM Classification     
I 35 19 (54%) 16 (46%) <0.005
II 27 24 (89%) 3 (11%)
III + IV 18 16 (89%) 2 (11%)  
Metastasis     
No 44 27 (61%) 17 (39%) 0.0055
Yes 36 32 (89%) 4 (11%)  
  1. Abbreviations: TNM, tumor-node-metastasis; a×2test. bMean age.